Pharma Journalist -

Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced the closing of a $180 million Series C financing round. SoftBank Vision Fund 2* led the financing…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab, an…
Read More...

National Resilience, Inc. (Resilience) and bluebird bio, Inc. announced a strategic alliance aimed to accelerate the early research, development and delivery of cell therapies. As part…
Read More...

Amgen and Teneobio announced an agreement under which Amgen will acquire Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called…
Read More...

SMi reports: Running alongside the main conference will be an interactive pre-conference workshop on 21st September 2021 on 'Target Discovery for RNA Therapeutics' Workshop Leader:…
Read More...

SMi Reports: Bringing together leading experts in the industry offering insights into device innovations, connected delivery and regulatory guidance for advanced parenteral systems.…
Read More...

Dyadic International, Inc. a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate…
Read More...

Lantern Pharma a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug…
Read More...

AbbVie and Calico Life Sciences announced an extension of their leading-edge collaboration to discover, develop and bring to market new therapies for patients with age-related diseases,…
Read More...

Cyclo Therapeutics, Inc. a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with…
Read More...